progabide has been researched along with oxidopamine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartholini, G; Oblin, A; Zivkovic, B | 1 |
1 other study(ies) available for progabide and oxidopamine
| Article | Year |
|---|---|
Progabide reverses the nigral substance P reduction induced by chronic impairment of dopaminergic transmission.
Topics: Animals; gamma-Aminobutyric Acid; Haloperidol; Hydroxydopamines; Male; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, GABA-A; Substance P; Substantia Nigra; Synaptic Transmission; Tyrosine 3-Monooxygenase | 1985 |